Is prevention better than the cure? How can the NHS and public health work closer to improve population health?

Pharma Market Access Insights - from Mtech Access

Dr Peter Brambleby (Independent Public Health Consultant) joins Tom Clarke (Director, Mtech Access) to discuss the role public health has played through the COVID pandemic and its importance to the population going forward.
This webinar forms part of our monthly Whispers’ Words of Wisdom series, in which we have in‑depth, comprehensive conversations with senior colleagues from the NHS. We explore what their immediate priorities are, what they see as the greatest challenges faced by the NHS, and how the NHS might respond to these challenges.
We were delighted to welcome Peter to the #WhispersWordsofWisdom series.
This episode was originally broadcast on 13th November 2020 as a webinar.
Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

챕터

1. Public health and the COVID response (00:03:54)

2. National vs local decision making for public health (00:08:20)

3. Business as usual in public health and how the COVID response differs (00:14:08)

4. How local authorities are navigating the route towards integration (00:17:52)

5. A national sickness service rather than a national health service - prevention vs the cure (00:22:45)

6. The economic and political arguments for prevention- dissonance between evidence and decision making (00:26:50)

7. What can public health initiatives do that the NHS can't? (00:32:30)

8. How do you measure the value of public health initiatives? (00:36:45)

9. How to address health inequalities (00:44:00)

10. The return from investing in prevention (00:49:15)

11. Perception of pharma and medtech in public health circles (00:51:50)

12. How can pharma and medtech add value to public health initiatives (00:54:15)